ArticleMolecular biology reports2025
Whole genome sequencing of Cryptosporidium from low DNA inputs without whole genome amplification.
Article in Molecular biology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundCryptosporidium is a protozoan parasite that causes diarrheal illness in humans and other animals and has a low infectious dose. The development of new tools to study and mitigate Cryptosporidium infection is aided by access to a diverse library of genomic material. However, culture methods to amplify the quantity of cells available from an individual isolate are not available, so Cryptosporidium DNA often falls below the input threshold for many genome sequencing methods. METHODS AND
resultsHere, we assess the suitability of whole genome amplification (WGA) free methods of obtaining high quality whole genome sequences from low inputs of DNA from Cryptosporidium. Three commercially available library kits from Illumina, New England Biolabs (NEB), and Qiagen were compared. Testing was conducted on extractions from Cryptosporidium oocyst counts ranging from 1 million (n = 1) to 1 oocyst (n = 4 for 100,000 and n = 8 for all other cell levels), representing DNA inputs ranging from approximately 5 ng to 0.005 pg. Similar performance was observed for the Illumina and NEB library prep kits for which 99% coverage of the reference genome was obtained from isolates containing between 1 million and 1,000 oocysts. Because only 36% of the Qiagen preps produced successful libraries, sequencing was not performed on this group.
conclusionsThis research indicates that high quality Cryptosporidium whole genome sequences can be generated from DNA extracted from as few as 1,000 oocysts, representing an estimated 5 pg of input DNA, without the need for WGA, creating new avenues for sequencing genomes from samples with limited DNA content.
Indexed as
Identifiers
41460366What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.